Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center

Preemptive biomarker profiling can be implemented into the diagnostic algorithm of a large Comprehensive Cancer Center. Substantial investments in diagnostics and administration are required.